A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

Stopped The Sponsor terminated the study due to futility. The decision to stop the study was not based on safety concerns.

Conditions

• Dilated Cardiomyopathy
• Lamin A/C Gene Mutation

Interventions

• DRUG: ARRY-371797 (PF-07265803)
• OTHER: Placebo

Sponsor

Pfizer